RGN1016
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGN1016, covering 2016-07-06 to 2016-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects [Phase 1]